3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
338
Other hematologic neoplasm
260
Lymphoid
205
Plasma cell
146
Classical hematology
89
Dermatologic
81
Sarcoma
59
Genitourinary
35
CNS
31
Breast
30
Gynecologic
28
Other neoplasm
25
Thoracic
7
Gastrointestinal
7
Head & Neck
4
Other solid neoplasm
2
Endocrine
2
Other
1
NET
1
Conditions
Neuroendocrine Tumors
208
Carcinoid Tumor
26
Neoplasms
22
Pancreatic Neoplasms
16
Gastro-enteropancreatic neuroendocrine tumor
14
Carcinoma, Neuroendocrine
11
Carcinoma
11
Adenoma, Islet Cell
11
Neoplasm Metastasis
10
Colorectal Neoplasms
9
Lung Neoplasms
8
Serotonin Syndrome
7
Prostatic Neoplasms
7
Adenocarcinoma
7
Pheochromocytoma
6
Gastrointestinal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Somatostatinoma
5
Neuroblastoma
5
Melanoma
5
Gastroenteropancreatic Neuroendocrine Tumors
5
Cholangiocarcinoma
5
Carcinoma, Renal Cell
5
Vipoma
4
Sarcoma
4
Rectal Neoplasms
4
Paraganglioma
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myeloproliferative Disorders
×
NET
×
Clear all
NCT01135849
2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
99 enrolled